Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1973 1
1974 1
1975 4
1976 3
1977 7
1978 8
1979 7
1980 11
1981 9
1982 7
1983 11
1984 16
1985 12
1986 8
1987 14
1988 11
1989 19
1990 8
1991 11
1992 21
1993 16
1994 24
1995 22
1996 14
1997 20
1998 29
1999 27
2000 24
2001 24
2002 22
2003 33
2004 38
2005 28
2006 43
2007 57
2008 55
2009 57
2010 61
2011 58
2012 58
2013 88
2014 82
2015 96
2016 94
2017 80
2018 100
2019 97
2020 99
2021 89
2022 74
2023 63
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

1,700 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and Treatment of Acromegaly: An Update.
Ershadinia N, Tritos NA. Ershadinia N, et al. Mayo Clin Proc. 2022 Feb;97(2):333-346. doi: 10.1016/j.mayocp.2021.11.007. Mayo Clin Proc. 2022. PMID: 35120696 Review.
Acromegaly is typically caused by a growth hormone-secreting pituitary adenoma, driving excess secretion of insulin-like growth factor 1. ...PubMed searches were conducted using the keywords growth hormone, acromegaly, pituitary adenoma, diagnosis, tre …
Acromegaly is typically caused by a growth hormone-secreting pituitary adenoma, driving excess secretion of insulin-like growt …
Somatostatin Analogs in Clinical Practice: a Review.
Gomes-Porras M, Cárdenas-Salas J, Álvarez-Escolá C. Gomes-Porras M, et al. Int J Mol Sci. 2020 Feb 29;21(5):1682. doi: 10.3390/ijms21051682. Int J Mol Sci. 2020. PMID: 32121432 Free PMC article. Review.
The Future of Somatostatin Receptor Ligands in Acromegaly.
Gadelha MR, Wildemberg LE, Kasuki L. Gadelha MR, et al. J Clin Endocrinol Metab. 2022 Jan 18;107(2):297-308. doi: 10.1210/clinem/dgab726. J Clin Endocrinol Metab. 2022. PMID: 34618894 Free PMC article. Review.
Modern approach to resistant acromegaly.
Giustina A, di Filippo L, Uygur MM, Frara S. Giustina A, et al. Endocrine. 2023 May;80(2):303-307. doi: 10.1007/s12020-023-03317-7. Epub 2023 Feb 15. Endocrine. 2023. PMID: 36790521
BACKGROUND: Targets of acromegaly treatment are normalization of biochemical values, removal/reduction/stabilization of the pituitary mass, control of clinical activity and mortality with a multimodal/multidisciplinary approach. Despite significant technological and pharma …
BACKGROUND: Targets of acromegaly treatment are normalization of biochemical values, removal/reduction/stabilization of the pituitary mass, …
Pediatric pituitary adenomas.
Walz PC, Drapeau A, Shaikhouni A, Eide J, Rugino AJ, Mohyeldin A, Carrau R, Prevedello D. Walz PC, et al. Childs Nerv Syst. 2019 Nov;35(11):2107-2118. doi: 10.1007/s00381-019-04293-y. Epub 2019 Jul 13. Childs Nerv Syst. 2019. PMID: 31302729 Review.
FOCUS OF REVIEW: In this review, we discuss the medical and surgical management of these tumors with a focus on clinical presentation, diagnostic identification, surgical approach, and associated adjuvant therapies. ...
FOCUS OF REVIEW: In this review, we discuss the medical and surgical management of these tumors with a focus on clinical presentation …
Pituitary tumors.
Mehta GU, Jane JA Jr. Mehta GU, et al. Curr Opin Neurol. 2012 Dec;25(6):751-5. doi: 10.1097/WCO.0b013e3283587bed. Curr Opin Neurol. 2012. PMID: 23108246 Review.
Acromegaly.
Chanson P, Salenave S, Kamenicky P. Chanson P, et al. Handb Clin Neurol. 2014;124:197-219. doi: 10.1016/B978-0-444-59602-4.00014-9. Handb Clin Neurol. 2014. PMID: 25248589 Review.
Pasireotide.
[No authors listed] [No authors listed] Prescrire Int. 2013 Nov;22(143):257-9. Prescrire Int. 2013. PMID: 24427831
Patients with Cushing's disease in whom surgical removal of the pituitary adenoma is not an option have few medical alternatives.The few available drugs are poorly evaluated and are used off-licence. Pasireotide, an injectable somatostatin analogue, is the first dru …
Patients with Cushing's disease in whom surgical removal of the pituitary adenoma is not an option have few medical alternativ …
Pituitary apoplexy.
Wichlińska-Lubińska M, Kozera G. Wichlińska-Lubińska M, et al. Neurol Neurochir Pol. 2019;53(6):413-420. doi: 10.5603/PJNNS.a2019.0054. Epub 2019 Nov 20. Neurol Neurochir Pol. 2019. PMID: 31745969
Pituitary apoplexy (PA) is a clinical syndrome caused by acute haemorrhage and/or infarction of the pituitary gland, generally within a frequently undiagnosed pituitary adenoma. ...This disease is rare but potentially life-threatening without rapid treatment. …
Pituitary apoplexy (PA) is a clinical syndrome caused by acute haemorrhage and/or infarction of the pituitary gland, generally within …
Acromegaly.
Scacchi M, Cavagnini F. Scacchi M, et al. Pituitary. 2006;9(4):297-303. doi: 10.1007/s11102-006-0409-4. Pituitary. 2006. PMID: 17077948 Review.
In doubtful cases, the lack of GH suppressibility below 1 microg/l (0.3 microg/l according to recent reports) after an oral glucose load will confirm the diagnosis. A pituitary adenoma is demonstrated in most cases by CT scan or MRI. ...Acromegaly is defined as cont …
In doubtful cases, the lack of GH suppressibility below 1 microg/l (0.3 microg/l according to recent reports) after an oral glucose load wil …
1,700 results